Bernengo MG - Search Results

1

Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma.

Bernengo MG, Lisa F, Meregalli M, Doveil GC. Bernengo MG, et al. Int J Tissue React. 1984;6(6):505-11. Int J Tissue React. 1984. PMID: 6335712

2

T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies.

Bernengo MG, Lisa F, Puiatti P, Meregalli M, Berruto G, Zina G. Bernengo MG, et al. Thymus. 1983 Apr;5(3-4):223-33. Thymus. 1983. PMID: 6224319

3

Thymostimulin therapy in melanoma patients: correlation of immunologic effects with clinical course.

Bernengo MG, Fra P, Lisa F, Meregalli M, Zina G. Bernengo MG, et al. Clin Immunol Immunopathol. 1983 Sep;28(3):311-24. doi: 10.1016/0090-1229(83)90098-3. Clin Immunol Immunopathol. 1983. PMID: 6603936

4

The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-up.

Bernengo MG, Lisa F, Meregalli M, De Matteis A, Zina G. Bernengo MG, et al. Cancer. 1983 Nov 15;52(10):1841-8. doi: 10.1002/1097-0142(19831115)52:10<1841::aid-cncr2820521014>3.0.co;2-n. Cancer. 1983. PMID: 6605188

5

Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma.

Sertoli MR, Bernengo MG, Ardizzoni A, Brunetti I, Falcone A, Vidili MG, Cusimano MP, Appino A, Doveil G, Fortini C, et al. Sertoli MR, et al. Among authors: bernengo mg. Oncology. 1989;46(2):96-8. doi: 10.1159/000226693. Oncology. 1989. PMID: 2710482

6

Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.

Fierro MT, Bertero M, Novelli M, Appino A, Doveil GC, Colonna S, Bernengo MG. Fierro MT, et al. Among authors: bernengo mg. Melanoma Res. 1993 Apr;3(2):127-31. Melanoma Res. 1993. PMID: 8518551 Clinical Trial.

7

[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)].

Bernengo MG, Doveil GC, Lisa F, Pippione M, Aloi FG, Stuardi C, Zina G. Bernengo MG, et al. G Ital Dermatol Venereol. 1986 Sep-Oct;121(5):311-26. G Ital Dermatol Venereol. 1986. PMID: 3793141 Italian. No abstract available.

8

Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance.

Doveil GC, Fierro MT, Novelli M, Appino A, Bertero M, Quaglino P, Bernengo MG. Doveil GC, et al. Among authors: bernengo mg. Dermatology. 1995;191(3):234-9. doi: 10.1159/000246551. Dermatology. 1995. PMID: 8534942

9

[Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985)].

Bernengo MG, Doveil GC, Lisa F, Stuardi C, Zina G. Bernengo MG, et al. G Ital Dermatol Venereol. 1987 Apr;122(4):143-53. G Ital Dermatol Venereol. 1987. PMID: 3610220 Italian. No abstract available.

10

The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of patients with warts.

Bernengo MG, de Matteis A, Meregalli M, Capella G, Zina G. Bernengo MG, et al. Br J Dermatol. 1980 Jan;102(1):11-6. doi: 10.1111/j.1365-2133.1980.tb05666.x. Br J Dermatol. 1980. PMID: 6966500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters